Hiroshi Yotsuyanagi

Research interests

Publications

• Humoral immune evasion of the omicron subvariants BQ.1.1 and XBB

  The Lancet Infectious Diseases · 2022 · https://doi.org/10.1016/s1473-3099(22)00816-7

• Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2

  Nature · 2022 · https://doi.org/10.1038/s41586-022-04856-1

• Efficacy and Safety of Ensitrelvir in Patients With Mild-to-Moderate Coronavirus Disease 2019: The Phase 2b Part of a Randomized, Placebo-Controlled, Phase 2/3 Study

  Clinical Infectious Diseases · 2022 · https://doi.org/10.1093/cid/ciac933

• The human microbiome and COVID-19: A systematic review

  PLoS ONE · 2021 · https://doi.org/10.1371/journal.pone.0253293

• Antibody titers against SARS-CoV-2 decline, but do not disappear for several months

  EClinicalMedicine · 2021 · https://doi.org/10.1016/j.eclinm.2021.100734

• Comparison of Rapid Antigen Tests for COVID-19

  Viruses · 2020 · https://doi.org/10.3390/v12121420

• High plasma linezolid concentration and impaired renal function affect development of linezolid-induced thrombocytopenia

  Journal of Antimicrobial Chemotherapy · 2013 · https://doi.org/10.1093/jac/dkt133

• The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice

  Nature Medicine · 1998 · https://doi.org/10.1038/2053

• Sialadenitis histologically resembling Sjögren syndrome in mice transgenic for hepatitis C virus envelope genes

  Proceedings of the National Academy of Sciences · 1997 · https://doi.org/10.1073/pnas.94.1.233

• Hepatitis C virus core protein induces hepatic steatosis in transgenic mice.

  Journal of General Virology · 1997 · https://doi.org/10.1099/0022-1317-78-7-1527

Current projects

No projects listed.